Director’s Declaration and Undertaking
Appointment/Resignation of Company Secretary
FDA Breakthrough Devices Designation
Initial Director’s Interest-Vincenzo Milazzo
Final Director’s Interest – John Stratilas
Director Resignation and Appointment
IQX Results of AGM FY2021
IQX Chairman’s Address
Wyss Validation Study SARS-CoV-2
OncoTex Gold Compound Licensing
